PA Medical News about Parkinson Disease Therapeutics

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Health State Values during the First Year of Drug Treatment in Early-Stage Parkinson's Disease: A Prospective, Population-Based, Cohort Study
Drugs & Aging, 10/26/09

Vossius C et al. – Patients with PD had lower SF–6D utility scores than controls at baseline. Patients started on antiparkinsonian drugs had an improvement in mean utility scores of 0.039 from 0.667 to 0.706. The ICER was €45 259 (2007 values) per QALY, of which two–thirds consisted of the costs of drugs and one–third represented the costs of clinical consultations. Drug treatment in patients with early–stage PD increases health state values, but the ICER is high. Further investigations will be necessary to capture the full consequences of treatment of PD and to evaluate the efficacy of disease management in this setting.